Use of carbon dioxide as negative contrast agent for magnetic resonance cholangiopancreatography

被引:7
|
作者
Chen, Ching-Wen [1 ]
Liu, Yi-Sheng [1 ]
Chen, Chiung-Yu [2 ]
Tsai, Hong-Ming [1 ]
Chen, Shu-Chen [1 ]
Chuang, Ming-Tsung [1 ]
机构
[1] Natl Cheng Kung Univ Hosp, Dept Diagnost Radiol, 138 Sheng Li Rd, Tainan 70428, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Dept Internal Med, Tainan 70428, Taiwan
来源
WORLD JOURNAL OF RADIOLOGY | 2011年 / 3卷 / 02期
关键词
Magnetic resonance cholangiopancreatography; Negative contrast medium; Gas-producing crystals; Carbon dioxide;
D O I
10.4329/wjr.v3.i2.47
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
AIM: To evaluate the effects of using CO2 as negative contrast agent in decreasing the overlapping on the pancreaticobiliary system from intestinal fluids. METHODS: We evaluated the magnetic resonance cholangiopancreatography (MRCP) images in 117 patients divided into two groups (group 1, without taking gas producing crystals to produce CO2, n = 64; group 2, with CO2, n = 53) in a 1.5T unit using MRCP sequence. Anatomic locations of intestinal fluids distribution, overlapping with common bile duct (CBD) and pancreatic duct (PD), were evaluated. RESULTS: In the group with CO2, the decrease in distribution of intestinal fluids was significant in the gastric antrum (P = 0.001) and duodenal bulb (P < 0.001), but not in the gastric fundus and body and in the second portion of the duodenum (P = 1.000, P = 0.171, and P = 0.584 respectively). In the group with CO2, the decrease in overlapping with CBD was significant (P < 0.001), but the decrease in overlapping with PD was not (P = 0.106). CONCLUSION: MRCP with carbon dioxide as negative contrast agent would decrease intestinal fluids in the gastric antrum and duodenal bulb, thereby decreasing overlapping with the CBD. (c) 2011 Baishideng. All rights reserved.
引用
收藏
页码:47 / 50
页数:4
相关论文
共 50 条
  • [31] The use of magnetic resonance cholangiopancreatography in surgical patients.
    Leytens, JW
    Proosdij, MP
    des Plantes, GZ
    Eddes, EH
    Hazenberg, HJ
    Schattenkerk, ME
    GASTROENTEROLOGY, 2000, 118 (04) : A205 - A205
  • [32] Magnetic resonance cholangiopancreatography: Current use and future applications
    Sahni, Vikram A.
    Mortele, Koenraad J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (09) : 967 - 977
  • [33] Magnetic resonance cholangiopancreatography
    Coakley, FV
    Qayyum, A
    GASTROINTESTINAL ENDOSCOPY, 2002, 55 (07) : S2 - S12
  • [34] Magnetic resonance cholangiopancreatography
    Bearcroft, PW
    Lomas, DJ
    GUT, 1997, 41 (02) : 135 - 137
  • [35] Magnetic resonance cholangiopancreatography
    Halefoglu, Ahmet Mesrur
    SEMINARS IN ROENTGENOLOGY, 2008, 43 (04) : 282 - 289
  • [36] Magnetic resonance cholangiopancreatography
    Coakley, FV
    Schwartz, LH
    JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1999, 9 (02): : 157 - 162
  • [37] Magnetic resonance cholangiopancreatography
    Lomas, DJ
    Gimson, A
    HOSPITAL MEDICINE, 2000, 61 (06): : 395 - 399
  • [38] Magnetic resonance cholangiopancreatography
    Bret, PM
    Reinhold, C
    ENDOSCOPY, 1997, 29 (06) : 472 - 486
  • [39] INTRAVENOUS CARBON-DIOXIDE AS AN ECHOCARDIOGRAPHIC CONTRAST AGENT
    MELTZER, RS
    SERRUYS, PW
    HUGENHOLTZ, PG
    ROELANDT, J
    JOURNAL OF CLINICAL ULTRASOUND, 1981, 9 (03) : 127 - 131
  • [40] INTRAVENOUS CARBON-DIOXIDE AS AN ECHOCARDIOGRAPHIC CONTRAST AGENT
    MELTZER, RS
    SERRUYS, PW
    HUGENHOLTZ, PG
    ROELANDT, J
    CIRCULATION, 1980, 62 (04) : 20 - 20